Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes - PubMed (original) (raw)
. 2004 Oct 29;279(44):45519-27.
doi: 10.1074/jbc.M408523200. Epub 2004 Aug 19.
Affiliations
- PMID: 15319441
- DOI: 10.1074/jbc.M408523200
Free article
Metalloproteinases and transforming growth factor-alpha mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human colonocytes
Hon-Wai Koon et al. J Biol Chem. 2004.
Free article
Abstract
Substance P (SP) participates in acute intestinal inflammation via binding to the G-protein-coupled neurokinin-1 receptor (NK-1R) and release of proinflammatory cytokines from colonic epithelial cells. SP also stimulates cell proliferation, a critical event in tissue healing during chronic colitis, via transactivation of the epidermal growth factor (EGF) receptor (EGFR) and activation of mitogen-activated protein kinase (MAPK). Here we examined the mechanism by which SP induces EGFR and MAPK activation. We used non-transformed human NCM460 colonocytes stably transfected with the human NK-1R (NCM460-NK-1R cells) as well as untransfected U373 MG cells expressing high levels of endogenous NK-1R. Exposure of both cell lines to SP (10(-7) m) stimulated EGFR activation (1 min) followed by extracellular signal-regulated protein kinase (ERK1/2) activation (2-5 min). SP-induced ERK1/2 activation was blocked by pretreatment with the metalloproteinase inhibitor Batimastat/GM6001, the EGFR phosphorylation inhibitor AG1478, and the tumor necrosis factor-alpha-converting enzyme (TACE) inhibitor TAPI-1. Pretreatment with antibodies against potential EGFR ligands suggested that transforming growth factor-alpha (TGFalpha), but not the other EGFR ligands EGF, heparin-binding EGF, or amphiregulin, mediates SP-induced EGFR transactivation. SP stimulated TGFalpha release into the extracellular space that was measurable within 2 min, and this release was inhibited by metalloproteinase inhibitors and the TACE inhibitor TAPI-1. SP also induced MAPK-mediated cell proliferation that was inhibited by TACE, matrix metalloproteinase (MMP), EGFR, and MEK1 inhibitors. Thus, in human colonocytes, NK-1R-induced EGFR and MAPK activation and cell proliferation involve matrix metalloproteinases (most likely TACE) and the release of TGFalpha. These signaling mechanisms may be involved in the protective effects of NK-1R in chronic colitis.
Similar articles
- Metalloproteinase-dependent transforming growth factor-alpha release mediates neurotensin-stimulated MAP kinase activation in human colonic epithelial cells.
Zhao D, Zhan Y, Koon HW, Zeng H, Keates S, Moyer MP, Pothoulakis C. Zhao D, et al. J Biol Chem. 2004 Oct 15;279(42):43547-54. doi: 10.1074/jbc.M401453200. Epub 2004 Jul 6. J Biol Chem. 2004. PMID: 15247267 - Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes.
Na X, Zhao D, Koon HW, Kim H, Husmark J, Moyer MP, Pothoulakis C, LaMont JT. Na X, et al. Gastroenterology. 2005 Apr;128(4):1002-11. doi: 10.1053/j.gastro.2005.01.053. Gastroenterology. 2005. PMID: 15825081 - Epidermal growth factor receptor transactivation mediates substance P-induced mitogenic responses in U-373 MG cells.
Castagliuolo I, Valenick L, Liu J, Pothoulakis C. Castagliuolo I, et al. J Biol Chem. 2000 Aug 25;275(34):26545-50. doi: 10.1074/jbc.M003990200. J Biol Chem. 2000. PMID: 10846186
Cited by
- The use of SP/Neurokinin-1 as a Therapeutic Target in Colon and Rectal Cancer.
Martín-García D, Téllez T, Redondo M, García-Aranda M. Martín-García D, et al. Curr Med Chem. 2024;31(39):6487-6509. doi: 10.2174/0109298673261625230924114406. Curr Med Chem. 2024. PMID: 37861026 Review. - Association of Neurokinin-1 Receptor Signaling Pathways with Cancer.
Rodriguez FD, Covenas R. Rodriguez FD, et al. Curr Med Chem. 2024;31(39):6460-6486. doi: 10.2174/0929867331666230818110812. Curr Med Chem. 2024. PMID: 37594106 Review. - Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders.
Singh RB, Naderi A, Cho W, Ortiz G, Musayeva A, Dohlman TH, Chen Y, Ferrari G, Dana R. Singh RB, et al. Ocul Surf. 2022 Jul;25:142-153. doi: 10.1016/j.jtos.2022.06.007. Epub 2022 Jun 30. Ocul Surf. 2022. PMID: 35779793 Free PMC article. Review. - Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR.
Zhang XW, Li L, Hu WQ, Hu MN, Tao Y, Hu H, Miao XK, Yang WL, Zhu Q, Mou LY. Zhang XW, et al. Cell Death Dis. 2022 Jan 10;13(1):41. doi: 10.1038/s41419-021-04485-y. Cell Death Dis. 2022. PMID: 35013118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous